Cargando…
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know
In response to the COVID‐19 pandemic, SARS‐CoV‐2 vaccines have been developed at an unparalleled speed, with 14 SARS‐CoV‐2 vaccines currently authorized. Solid‐organ transplant (SOT) recipients are at risk for developing a higher rate of COVID‐19‐related complications and therefore they are at prior...
Autores principales: | Giannella, Maddalena, Pierrotti, Lígia C., Helanterä, Ilkka, Manuel, Oriol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646251/ https://www.ncbi.nlm.nih.gov/pubmed/34450686 http://dx.doi.org/10.1111/tri.14029 |
Ejemplares similares
-
Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
por: Åsberg, Anders, et al.
Publicado: (2020) -
Donor-derived infections in solid organ transplant recipients
por: Peghin, Maddalena, et al.
Publicado: (2023) -
An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient
por: Ibrahim, Uroosa, et al.
Publicado: (2016) -
BK polyoma virus infection and renal disease in non-renal solid organ transplantation
por: Kuppachi, Sarat, et al.
Publicado: (2016) -
Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)